Live Breaking News & Updates on Tropion Lung05

Stay updated with breaking news from Tropion lung05. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Antibody-Drug Conjugates in EGFR-Mutant NSCLC

The panel discusses the use of antibody-drug conjugates for patients with EGFR-mutant non–small cell lung cancer, with a focus on the HERTHENA-Lung01 and TROPION-Lung05 studies. ....

Evolving Treatment Paradigm , Advanced Non , Small Cell Lung Cancer , Drug Conjugates , Non Small Cell Lung Cancer , Advanced Non Small Cell Lung Cancer , Advanced Nsclc , Nsclc Treatment , Egfr Mutant Lung Cancer , Egfr Mutated Lung Cancer , Second Line Treatment , Herthena Lung01 , Tropion Lung05 , Patritumab Deruxtecan , Datopotamab Deruxtecan ,

Dr Passaro on the Significance of the TROPION-Lung05 Trial of Dato-DXd in NSCLC

Antonio Passaro, MD, PhD, medical oncologist, Division of Thoracic Oncology, European Institute of Oncology, discusses the significance of data from the phase 2 TROPION-Lung05 trial of datopotamab deruxtecan in patients with non–small cell lung cancer. ....

Antonio Passaro , Division Of Thoracic Oncology , European Institute Of Oncology , Thoracic Oncology , European Institute , Tropion Lung05 , Dato Dxd ,